GrossP.A., BarrettT.L., DellingerP.E.. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America.Clin Infect Dis.1994; 18: 421.
2.
MakiD.G., MermelL.A.. Infections due to infusion therapy. In: BennettJ.V., BrachmanP.S., eds. Hospital Infections.Philadelphia, Pa: Lippincott-Raven;1998.
3.
PearsonM.L.. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee.Infect Control Hosp Epidemiol.1996; 17: 438–473.
4.
JarvisW.R., EdwardsJ.E., CulverD.H.. Nosocomial infection rates in adult and pediatric intensive care units in the United States.Am J Med.1991; 91(suppl 3B): 185S–191S.
5.
MayhallC.G.. Diagnosis and management of infections of implantable devices used for prolonged venous access.Curr Clin Top Infect Dis.1992; 12: 83–110.
6.
PittetD., TararaD., WenzelR.P.. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality.JAMA.1994; 271: 1598–1601.
7.
HeiselmanD.. Nosocomial bloodstream infections in the critically ill.JAMA.1994; 272: 1819–1820.
8.
EdgeworthJ.D., TreacherD.F., EykynS.J.. A 25-year study of nosocomial bacteremia in an adult intensive care unit.Crit Care Med.1999; 27: 1421–1428.
9.
MakiD.G., StolzS.M., WheelerS.. Prevention of central venous catheter–related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.Ann Intern Med.1997; 127: 257–266.
10.
MermelL.A., McCormickR.D., SpringmanS.R.. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular sub-typing.Am J Med.1991; 91: 197S–205S.
11.
RaadI., CostertonW., SabharwalU.. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.J Infect Dis.1993; 168: 400–407.
12.
LopesJ.D., dos ReisM., BrentaniR.R.. Presence of laminin receptors in Staphylococcus aureus.Science.1985; 229: 275–277.
13.
HerrmannM., SuchardS.J., BoxerL.A.. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.Infect Immun.1991; 59: 279–288.
14.
HerrmannM., VaudauxP.E., PittetD.. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material.J Infect Dis.1988; 158: 693–701.
15.
VaudauxP., PittetD., HaeberliA.. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters.J Infect Dis.1993; 167: 633–641.
16.
NilssonM., FrykbergL., FlockJ.I.. A fibrinogen-binding protein of Staphylococcus epidermidis.Infect Immun.1998; 66: 2666–2673.
17.
HannaH.A., RaadI.. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients.Infect Control Hosp Epidemiol.2001; 22: 165–166.
18.
MermelL.A.. Bacteriology, safety and prevention of infection associated with continuous intravenous infusions.Blood Coagul Fibrinolysis.1996; 7(suppl 1): S45–S51.
19.
KiehnT.E., ArmstrongD.. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.Eur J Clin Microbiol Infect Dis.1990; 9: 869–872.
20.
KristinssonK.G.. Diagnosis of catheter-related infections. In: SeifertH., JansenB., FarrB.M., eds. Catheter-Related Infections.New York, NY: M Dekker;1997.
21.
CooperG.L., HopkinsC.C.. Rapid diagnosis of intravascular catheter-associated infection by direct gram staining of catheter segments.N Engl J Med.1985; 312: 1142–1147.
22.
KiteP., DobbinsB.M., WilcoxM.H.. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal.Lancet.1999; 354: 1504–1507.
23.
MakiD.G., WeiseC.E., SarafinH.W.. A semiquantitative culture method for identifying intravenous-catheter-related infection.N Engl J Med.1977; 296: 1305–1309.
24.
CleriD.J., CorradoM.L., SeligmanS.J.. Quantitative culture of intravenous catheters and other intravascular inserts.J Infect Dis.1980; 141: 781–786.
25.
Brun-BuissonC., AbroukF., LegrandP.. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures.Arch Intern Med.1987; 147: 873–877.
26.
SchmittS.K., KnappC., HallG.S.. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.J Clin Microbiol.1996; 34: 508–511.
SherertzR.J., RaadI.I., BelaniA.. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory.J Clin Microbiol.1990; 28: 76–82.
29.
HeardS.O., WagleM., VijayakumarE.. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.Arch Intern Med.1998; 158: 81–87.
30.
WidmerA.F., NettlemanM., FlintK.. The clinical impact of culturing central venous catheters. A prospective study.Arch Intern Med.1992; 152: 1299–1302.
31.
DesJardinJ.A., FalagasM.E., RuthazerR.. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer.Ann Intern Med.1999; 131: 641–647.
32.
FanS.T., Teoh-ChanC.H., LauK.F.. Evaluation of central venous catheter sepsis by differential quantitative blood culture.Eur J Clin Microbiol Infect Dis.1989; 8: 142–144.
33.
CapdevilaJ.A., PlanesA.M., PolomarM.. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis.Eur J Clin Microbiol Infect Dis.1992; 11: 403–407.
34.
KiteP., DobbinsB.M., WilcoxM.H.. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter-related sepsis.J Clin Pathol.1997; 50: 278–282.
35.
BlotF., SchmidtE., NitenbergG.. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis.J Clin Microbiol.1998; 36: 105–109.
36.
BlotF., NitenbergG., ChachatyE.. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures.Lancet.1999; 354: 1071–1077.
37.
WhitmanE.D., BoatmanA.M.. Comparison of diagnostic specimens and methods to evaluate infected venous access ports.Am J Surg.1995; 170: 665–670.
38.
DouardM.C., ArletG., LonguetP.. Diagnosis of venous access port related infections.Clin Infect Dis.1999; 29: 1197–1202.
39.
FidalgoS., VazquezF., MendozaM.C.. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features.Rev Infect Dis.1990; 12: 520–528.
40.
PollackP.F., KaddenM., ByrneW.J.. 100 patient years’ experience with the Broviac silastic catheter for central venous nutrition.JPEN J Parenter Enteral Nutr.1981; 5: 32–36.
41.
HerrmannM., PetersG.. Catheter-associated infections caused by coagulase-negative staphylococci: clinical and biological aspects. In: SeifertH., JansenB., FarrB.M., eds. Catheter-Related Infections.New York, NY: M Dekker;1997.
42.
RaadI., DavisS., KhanA.. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococci bacteremia.Infect Control Hosp Epidemiol.1992; 13: 215–221.
43.
RaadI.I., SabbaghM.F.. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review.Clin Infect Dis.1992; 14: 75–82.
44.
RaadI., NarroJ., KhanA.. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.Eur J Clin Microbiol Infect Dis.1992; 11: 675–682.
GreeneJ.N.. Infections related to vascular access devices.Cancer Control.1996; 3: 456–464.
47.
RosenA.B., FowlerV.G.Jr., CoreyG.R.. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia.Ann Intern Med.1999; 130: 810–820.
48.
KrywdaE., GotoffR., AndrisD.. Antibiotic lock treatment (ALT): impact on catheter salvage and cost savings. In: Program and Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Francisco, Calif; 1995: AJ4. Abstract.
49.
GuedonC., NouvellonM., LalaudeO.. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition.JPEN J Parenter Enteral Nutr.2002; 26: 109–113.
50.
StrindenW.D., HelgersonR.B., MakiD.G.. Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management.Ann Surg.1985; 202: 653–658.
51.
RaviglioneM.C., BattanR., Pablos-MendezA.. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome.Am J Med.1989; 86(pt 2): 780–786.
LeccionesJ.A., LeeJ.W., NavarroE.E.. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes.Clin Infect Dis.1992; 14: 875–883.
54.
AshbyM.J., NealeJ.E., KnottS.J.. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli.J Antimicrob Chemother.1994; 33: 443–452.
55.
StrindenW.D., HelgersonR.B., MakiD.G.. Candida septic thrombosis of the great central veins associated with central catheters.Ann Surg.1985; 202: 653–658.
56.
DugdaleD.C., RamseyP.G.. Staphylococcus aureus bacteremia in patients with Hickman catheters.Am J Med.1990; 89: 137–141.
57.
GillM.V., KleinN.C., CunhaB.A.. Unusual organisms causing intravenous line infections in compromised hosts. I. Bacterial and algal infections.Infect Dis Clin Pract.1996; 5: 244–255.
58.
RaadI., BompartF., HachemR.. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia.Eur J Clin Microbiol Infect Dis.1999; 18: 199–202.
59.
GarciaR., RaadI.. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.Eur J Clin Microbiol Infect Dis.1996; 15: 933–936.
60.
MoelleringR.C.Jr.. A novel antimicrobial agent joins the battle against resistant bacteria.Ann Intern Med.1999; 130: 155–157.
61.
MermelL.A., FarrB.M., SherertzR.J.. Guidelines for the management of intravascular catheter-related infections.J Intraven Nurs.2001; 24: 180–205.
62.
SteinbergJ.P., ClarkC.C., HackmanB.O.. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance.Clin Infect Dis.1996; 23: 255–259.
63.
ZeylemakerM.M., JaspersC.A., van KraaijM.G.. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia.Eur J Clin Microbiol Infect Dis.2001; 20: 380–384.
64.
MeunierF.. Management of candidemia.N Engl J Med.1994; 331: 1371–1372.
65.
AnaissieE.J., VartivarianS.E., Abi-SaidD.. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.Am J Med.1996; 101: 170–176.
66.
PfallerM.A., BarryA.L.. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.Mycopathologia.1995; 130: 3–9.
67.
BerrouaneY.F., HollisR.J., PfallerM.A.. Strain variation among and antifungal susceptibilities of isolates of Candida krusei.J Clin Microbiol.1996; 34: 1856–1858.
68.
RexJ.H., WalshT.J., SobelJ.D.. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.Clin Infect Dis.2000; 30: 662–678.
69.
RexJ.H., BennettJ.E., SugarA.M.. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.N Engl J Med.1994; 331: 1325–1330.
70.
MermelL.A., FarrB.M., SherertzR.J.. Guidelines for the management of intravascular catheter-related infections.Clin Infect Dis.2001; 32: 1249–1272.
71.
PettigrewR.A., LangS.D., HaydockD.A.. Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis.Br J Surg.1985; 72: 52–55.
72.
RaadI., DavisS., KhanA.. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia.Infect Control Hosp Epidemiol.1992; 13: 215–221.
73.
LiJ.S., SextonD.J., MickN.. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.Clin Infect Dis.2000; 30: 633–638.
RosenA.B., FowlerV.G.Jr., CoreyG.R.. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia.Ann Intern Med.1999; 130: 810–820.
76.
PeacockS.J., EddlestonM., EmptageA.. Positive intravenous line tip cultures as predictors of bacteremia.J Hosp Infect.1998; 40: 35–38.
HogevikH., AlestigK.. Fungal endocarditis: a report on seven cases and a brief review.Infection.1996; 24: 17–21.
79.
GarrisonP.K., FreedmanL.R.. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.Yale J Biol Med.1970; 42: 394–410.
80.
WidmerA.F., NettlemanM., FlintK.. The clinical impact of culturing central venous catheters. A prospective study.Arch Intern Med.1992; 152: 1299–1302.
KentosA., DufayeP., JacobsF.. Candida albicans septic thrombosis of the right atrium is associated with a central venous catheter.Clin Infect Dis.1995; 21: 440–442.
MakiD.G., McCormickR.D., UmanS.J.. Septic endarteritis due to intra-arterial catheters for cancer chemotherapy. I. Evaluation of an outbreak. II. Risk factors, clinical features and management. III. Guidelines for prevention.Cancer.1979; 44: 1228–1240.
BenoitD., DecruyenaereJ., VandewoudeK.. Management of candidal thrombophlebitis of the central veins: case report and review.Clin Infect Dis.1998; 26: 393–397.
87.
PrinceA., HellerB., LevyJ.. Management of fever in patients with central vein catheters.Pediatr Infect Dis.1986; 5: 20–24.
88.
WilsonW.R., KarchmerA.W., DajaniA.S.. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms American Heart Association.JAMA.1995; 274: 1706–1713.